Loading...
Images of Oula Penate Medina
(0 from 0 )News
FDA approves ultrasmall silica inorganic nanoparticle INDA for...
www.news-medical.net
Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies,...
Replicon - Corporate Finance CTT Cancer Targeting...
www.replicon.fi
Replicon Group on riippumaton neuvonantaja kasvuyritysten rahoituksessa ja yrityskaupoissa sekä niihin liittyvissä strategisissa kysymyksissä. Fokusalueillamme...
Nanotechnology Now - Press Release: Novel Cancer-Targeting...
www.nanotech-now.com
Memorial Sloan-Kettering nanochemist Oula Penate Medina, PhD, notes that " this is an important trial in that it will help to answer a number of ...
eFinland | Nano Brings Targeted Medication
e.finland.fi
New, intelligent targeted medicines and materials will focus treatment where it is needed," says Oula Penate Medina the CEO of CTT Cancer Targeting ...
sorted by relevance / date